Tianjin Chase Sun Pharmaceutical Co.,Ltd (300026.SZ)
CNY 4.11
(0.0%)
CNY 4.11
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 6.12 Billion | 6.65 Billion | 7.67 Billion | 6.48 Billion | 5 Billion | 4.22 Billion |
| Cost of Revenue | 3 Billion | 2.81 Billion | 3.22 Billion | 2.81 Billion | 1.6 Billion | 1.22 Billion |
| Gross Profit | 3.11 Billion | 3.83 Billion | 4.44 Billion | 3.66 Billion | 3.39 Billion | 2.99 Billion |
| Operating Expenses | 2.81 Billion | 2.99 Billion | 3.3 Billion | 2.83 Billion | 2.73 Billion | 2.37 Billion |
| Selling, General and Administrative Expenses | 2.34 Billion | 2.42 Billion | 2.71 Billion | 2.3 Billion | 2.2 Billion | 1.91 Billion |
| Research and Development Expenses | 215.58 Million | 236.68 Million | 203.35 Million | 180.15 Million | 182.52 Million | 142.04 Million |
| Other Expenses | - | 3.85 Million | -21.01 Million | 29.3 Million | 1.18 Million | 32.46 Million |
| Cost and Expenses | 5.61 Billion | 5.8 Billion | 6.52 Billion | 5.65 Billion | 4.34 Billion | 3.59 Billion |
| Operating Income | 489.26 Million | 712.51 Million | 875.18 Million | 654.11 Million | 483.24 Million | 291.58 Million |
| Interest Expense | 67.42 Million | 69.66 Million | 50.1 Million | 30.07 Million | 10.76 Million | 11.13 Million |
| Income Tax Expense | 105.25 Million | 95.39 Million | 183.32 Million | 123.73 Million | 76 Million | 108.14 Million |
| Earnings before Tax | 606.82 Million | 716.37 Million | 854.17 Million | 683.41 Million | 484.43 Million | 324.05 Million |
| Net Income | 506.63 Million | 624.24 Million | 687.31 Million | 573.39 Million | 402.52 Million | 210.79 Million |
| Earnings Per Share Basic | 0.17 | 0.21 | 0.23 | 0.19 | 0.13 | 0.07 |
| Earnings Per Share Diluted | 0.17 | 0.21 | 0.23 | 0.19 | 0.13 | 0.07 |
| Weighted Average Shares Outstanding | 2.98 Billion | 3 Billion | 3 Billion | 3 Billion | 3 Billion | 2.98 Billion |
| Weighted Average Shares Outstanding (Diluted) | 2.98 Billion | 3 Billion | 3 Billion | 3 Billion | 3 Billion | 3.01 Billion |
| Gross Margin | 0.51 | 0.58 | 0.58 | 0.57 | 0.68 | 0.71 |
| EBIT Margin | 0.17 | 0.18 | 0.18 | 0.16 | 0.17 | 0.19 |
| Profit Margin | 0.08 | 0.09 | 0.09 | 0.09 | 0.08 | 0.05 |
| EBITDA | 1.04 Billion | 1.13 Billion | 1.2 Billion | 903.47 Million | 653.36 Million | 466.57 Million |
| Earnings Before Tax Margin | 0.08 | 0.11 | 0.11 | 0.10 | 0.10 | 0.07 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 1.44 Billion | 1.51 Billion | 1.44 Billion | 6.12 Billion | 1.2 Billion | 1.49 Billion |
| Cost of Revenue | 712.84 Million | 741.73 Million | 713.22 Million | 3 Billion | 662.33 Million | 731.45 Million |
| Gross Profit | 731.99 Million | 773.82 Million | 734.6 Million | 3.11 Billion | 542.5 Million | 767.5 Million |
| Operating Expenses | 669.23 Million | 686.3 Million | 655.31 Million | 2.55 Billion | 584.8 Million | 585.8 Million |
| Selling, General and Administrative Expenses | 956.77 Million | 637.51 Million | 608.68 Million | - | 498.93 Million | 703.73 Million |
| Research and Development Expenses | 60.4 Million | 44.71 Million | 44.35 Million | - | 61.51 Million | 52.87 Million |
| Other Expenses | -347.95 Million | -4.07 Million | -2.26 Million | -207.55 Million | -85.86 Million | 39.43 Million |
| Cost and Expenses | 1.38 Billion | 1.42 Billion | 1.36 Billion | 5.61 Billion | 1.23 Billion | 1.31 Billion |
| Operating Income | 36.81 Million | 87.52 Million | 79.29 Million | 488.44 Million | -74.66 Million | 146.46 Million |
| Interest Expense | 11.54 Million | 13.36 Million | 15.21 Million | 61.57 Million | 15.31 Million | 12.68 Million |
| Income Tax Expense | -7.76 Million | -5.25 Million | 22.53 Million | 99.81 Million | 17.74 Million | 23.66 Million |
| Earnings before Tax | 32.01 Million | 93.95 Million | 77.18 Million | 629.01 Million | 34.98 Million | 185.9 Million |
| Net Income | 20.12 Million | 90.11 Million | 58.12 Million | 506.63 Million | 17.23 Million | 163.3 Million |
| Earnings Per Share Basic | 0.01 | 0.03 | 0.02 | - | 0.01 | 0.05 |
| Earnings Per Share Diluted | 0.01 | 0.03 | 0.02 | - | 0.01 | 0.05 |
| Weighted Average Shares Outstanding | 3 Billion | 3 Billion | 3 Billion | 3 Billion | 3 Billion | 3 Billion |
| Weighted Average Shares Outstanding (Diluted) | 3 Billion | 3 Billion | 3 Billion | 3 Billion | 3 Billion | 3 Billion |
| Gross Margin | 0.51 | 0.51 | 0.51 | 0.51 | 0.45 | 0.51 |
| EBIT Margin | 0.03 | 0.12 | 0.08 | - | 0.02 | 0.15 |
| Profit Margin | 0.01 | 0.06 | 0.04 | 0.08 | 0.01 | 0.11 |
| EBITDA | 43.56 Million | 181.07 Million | 119.44 Million | - | 18.18 Million | 224.74 Million |
| Earnings Before Tax Margin | 0.03 | 0.06 | 0.05 | 0.08 | -0.06 | 0.10 |
300011
0188
NDA
SUPR
BLDE
CODI-PA